A single dose of CRISPR base editing durably lowered ANGPTL3 in primates, offering a potential new approach to treating high ...
The independent diagnostics company wants to capitalize on aging lab infrastructure, changing testing networks, and asset ...
For the Association of Molecular Pathology, disruptive technologies and clinical implementation barriers shape patient care ...
More than a decade after Theranos collapsed, diagnostics companies are pursuing its vision and questioning whether the lab ...
Antisense oligonucleotides (ASOs) are opening new treatment possibilities for rare genetic diseases, including those caused by mutations too uncommon to attract conventional drug development. But the ...
Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy ...
A high-throughput drug screening platform uses DNA nanoswitches to identify compounds capable of changing how proteins ...
The human pangenome improved somatic mutation detection, revealing thousands of candidate mutations in a melanoma cell line.
An Australian study suggests a supervised food challenge may be the best way to diagnose peanut allergy in young children.
Dyve Biosciences targets acidic microenvironments in cancer and inflammatory conditions through transdermal delivery.
Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...
Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results